M4773

Metaraminol

• Synonym(e): (−)-m-Hydroxyphenylpropanolamin -bitartrat (Salz)
• Empirische Formel (Hill-System): C₉H₁₃NO₂ · C₄H₆O₆
• CAS-Nummer: 33402-03-8
• Molekulargewicht: 317.29
• EG-Nummer: 251-502-3
• MDL-Nummer: MFCD00238763
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 24896944
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 200
• Ersteller: Merck & Co., Inc., Kenilworth, NJ, U.S.
• SMILES String: O[C@H]([C@@H](O)C(O)=O)C(O)=O.C[C@H](N)[C@H](O)c1cccc(O)c1
• InChI: 1S/C9H13NO2.C4H6O6/c1-6(10)9(12)7-3-2-4-8(11)5-7;5-1(3(7)8)2(6)4(9)10/h2-6,9,11-12H,10H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t6-,9-;1-,2-/m01/s1
• InChIKey: VENXSELNXQXCNT-IJYXXVHRSA-N

Beschreibung

Anwendung

Metaraminol (+)-bitartrate salt has been used to study the effects of adrenergic agonists in the mouse model of endometriosis.[1]

Biochem./physiol. Wirkung

α-adrenoceptor agonist.
Metaraminol may serve as a false sympathetic transmitter.[2] It is a mixed α - and β-adrenergic agonist.[3]

Leistungsmerkmale und Vorteile

This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Piktogramme: GHS06
• Signalwort: Danger
• H-Sätze: H301 + H311 + H331
• P-Sätze: P261 - P264 - P280 - P301 + P310 - P302 + P352 + P312 - P304 + P340 + P311
• Gefahreneinstufungen: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral
• Lagerklassenschlüssel: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Persönliche Schutzausrüstung: Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges